Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Phenotypic Differences between Patients with Smoking Chronic Obstructive Pulmonary Disease and Non-smoking Chronic Obstructive Pulmonary Disease

View through CrossRef
Background: In low- and middle-income countries, causes other than tobacco smoking contribute more to the development of chronic obstructive pulmonary disease (COPD). In India, non-smoking-related COPD (NS-COPD) is common due to the high prevalence of pulmonary tuberculosis and biomass fuel exposure. Our study aims to know the phenotypic differences between smoking-related COPD (S-COPD) and NS-COPD patients. Materials and Methods: The study included 217 patients, who visited the outdoor department of a tertiary care center. A detailed clinical history was obtained; radiological and hematological investigations, spirometry, and a 6-min walk test were performed. Results: Of 217 patients, 100 had S-COPD, and 117 had NS-COPD. Male patients were predominantly affected (P < 0.001) in both groups. There were significant differences in the age group (P < 0.001), body mass index (P < 0.045), blood hemoglobin levels (P < 0.02), forced vital capacity (FVC) (P = 0.02), postbronchodilator reversibility in forced expiratory volume in 1 s (FEV1) (P < 0.006), and FEV1/FVC ratio (P < 0.001) between patients with smoking and S-COPD and NS-COPD. Emphysema was more common in S-COPD, whereas COPD-bronchiectasis overlap was more common among NS-COPD patients. Cough was more common, and airflow obstruction was less severe in nonsmokers. There was no significant difference in the exercise capacity. Conclusion: The NS-COPD patients present at younger age, with more COPD-bronchiectasis overlap phenotype. They have less severe airflow obstruction and more postbronchodilator reversibility. Understanding phenotypic characteristics is necessary for accurate diagnosis and management of COPD in nonsmokers.
Title: Phenotypic Differences between Patients with Smoking Chronic Obstructive Pulmonary Disease and Non-smoking Chronic Obstructive Pulmonary Disease
Description:
Background: In low- and middle-income countries, causes other than tobacco smoking contribute more to the development of chronic obstructive pulmonary disease (COPD).
In India, non-smoking-related COPD (NS-COPD) is common due to the high prevalence of pulmonary tuberculosis and biomass fuel exposure.
Our study aims to know the phenotypic differences between smoking-related COPD (S-COPD) and NS-COPD patients.
Materials and Methods: The study included 217 patients, who visited the outdoor department of a tertiary care center.
A detailed clinical history was obtained; radiological and hematological investigations, spirometry, and a 6-min walk test were performed.
Results: Of 217 patients, 100 had S-COPD, and 117 had NS-COPD.
Male patients were predominantly affected (P < 0.
001) in both groups.
There were significant differences in the age group (P < 0.
001), body mass index (P < 0.
045), blood hemoglobin levels (P < 0.
02), forced vital capacity (FVC) (P = 0.
02), postbronchodilator reversibility in forced expiratory volume in 1 s (FEV1) (P < 0.
006), and FEV1/FVC ratio (P < 0.
001) between patients with smoking and S-COPD and NS-COPD.
Emphysema was more common in S-COPD, whereas COPD-bronchiectasis overlap was more common among NS-COPD patients.
Cough was more common, and airflow obstruction was less severe in nonsmokers.
There was no significant difference in the exercise capacity.
Conclusion: The NS-COPD patients present at younger age, with more COPD-bronchiectasis overlap phenotype.
They have less severe airflow obstruction and more postbronchodilator reversibility.
Understanding phenotypic characteristics is necessary for accurate diagnosis and management of COPD in nonsmokers.

Related Results

Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
Background. In patients with frequent exacerbations of chronic obstructive pulmonary disease occurring against the background of hypertension, there is a high level of personal neu...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
DYSLIPIDEMIA AS RISK FACTOR OF ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
DYSLIPIDEMIA AS RISK FACTOR OF ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Introduction: Atherosclerosis is one of the most common co-morbidities observed in chronic obstructive pulmonary disease. A better understanding of mechanisms of atherosclerosis in...
Dispelling Myths and Misconceptions about Chronic Obstructive Pulmonary Disease
Dispelling Myths and Misconceptions about Chronic Obstructive Pulmonary Disease
Introduction: Chronic obstructive pulmonary disease is one of the major causes of disability and mortality in the world. Despite better efforts to understand this disease, there ar...
Health Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients
Health Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients
Objective: To determine the health-related quality of life among patients suffering from chronic obstructive pulmonary disease. Study Design: Cross sectional analytical study. Plac...

Back to Top